Remove Diabetes Remove Family Remove Government Remove Manufacturing
article thumbnail

Biased research, aggressive sales, harmful drugs

The Health Policy Exchange

Food and Drug Administration to market a new drug is a critical waypoint along the path to profits for pharmaceutical manufacturers. In the meantime, lobbyists working for the drug manufacturers successfully blocked efforts by Medicare administrators to stop paying for the higher (harmful) doses. Could the FDA and other U.S.

article thumbnail

‘MAHA Report’ Calls for Fighting Chronic Disease, but Trump and Kennedy Have Yanked Funding

Physician's Weekly

But the administration is seeking to cut government funding that could serve as a counterweight. Kennedy has cited diabetes as part of a crisis in children’s health. government is committed to fostering radical transparency and gold-standard science.” The report calls for “fearless gold-standard science.”